FDA Grants QIDP Designation to The Medicines Company's Investigational Antibiotic Oritavancin

Marketwired
FDA Grants QIDP Designation to The Medicines Company's Investigational Antibiotic Oritavancin
The Medicines Company Logo
View Comments (0)